Device Trial Radar · NCT06059638
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
349
Actual
Start
Dec 27, 2023
Primary completion
Jan 2027
Study completion Aug 2029
Sponsor
- Lead sponsor
- Orchestra BioMed, IncNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Medtronic
- First posted
- Sep 28, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.
Conditions
- Hypertension
- Hypertension, Systolic
- Hypertension, Essential
Interventions
Medtronic Astra/Azure DR MRI IPG with AVIM therapy ActivatedDevice
Antihypertensive therapy utilizing atrioventricular interval modulation.
Medtronic Astra/Azure DR MRI IPG with AVIM therapy DeactivatedDevice
AVIM therapy is deactivated
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from Baseline in the Mean 24-hour ambulatory systolic blood pressure (aSBP) at 3 MonthsTime frame: Baseline and 3 months post randomization
- Freedom from Unanticipated Serious Adverse Device Effects (USADE)Time frame: 3 months post randomization
Locations
92 sites in 15 countries. Site status is shown where the registry gives one.
HonorHealth
Scottsdale, Arizona
Adventist Health Glendale
Glendale, California
Hoag Memorial Hospital Presbyterian
Newport Beach, California
89 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.